ReShape Lifesciences Inc (RSLS):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:ReShape Lifesciences Inc (RSLS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6383
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ReShape Lifesciences Inc (ReShape), formerly known as EnteroMedics Inc is a medical device company that develops minimally invasive medical devices to treat obesity and metabolic diseases. The company develops vBloc, a therapy used in the treatment of gastrointestinal and neurometabolic diseases; and ReShape Balloon System, which is indicated for weight reduction when used in conjunction with diet and exercise, in obese patients and obesity-related comorbid conditions. ReShape’s vBloc therapy is a rechargeable neuroregulator that is implanted subcutaneously and attached to the vagal nerve. The company’s product vBloc is a minimally invasive therapy that does not alter patient’s anatomy. ReShape is headquartered in San Clemente, California, the US.

ReShape Lifesciences Inc (RSLS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ReShape Lifesciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ReShape Lifesciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ReShape Lifesciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ReShape Lifesciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ReShape Lifesciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ReShape Lifesciences Inc, Medical Equipment, Deal Details 11
Venture Financing 11
EnteroMedics Raises USD61 Million in a Venture Financing 11
Reshape Medical Raises USD11 Million in Venture Financing 12
Reshape Medical Raises USD38 Million in Series D Financing 13
Reshape Medical Raises Additional USD3.5 Million in Venture Financing 15
Reshape Medical Raises Additional USD1.25 Million in Venture Financing 16
Reshape Medical Raises USD4 Million in Venture Financing 17
Reshape Medical Raises US$16 Million In Venture Financing 18
Reshape Medical Raises US$1.5 Million In Venture Financing 19
Partnerships 20
EnteroMedics Enters into Agreement with Galvani Bioelectronics 20
Equity Offering 21
ReShape Lifesciences Plans to Raise USD15 Million in Public Offering of Shares 21
ReShape Lifesciences Prices Public Offering of Shares for USD0.5 Million 22
ReShape Lifesciences to Raise USD0.6 Million in Private Placement of Shares 23
ReShape Lifesciences Raises USD2.7 Million in Private Placement of Shares 24
ReShape Lifesciences Prices Registered Direct Offering of Shares for USD1.44 Million 25
ReShape Lifesciences to Raise USD6 Million in Private Placement of Shares and Warrants 26
EnteroMedics Raises USD20 Million in Public Offering of Units 28
EnteroMedics Raises USD19 Million in Public Offering of Units 30
EnteroMedics Raises USD16 Million in Public Offering of Units 32
EnteroMedics Announces Public Offering Of Common Stock For US$20 Million 34
EnteroMedics Completes Public Offering Of Common Stock And Warrants For US$13 Million 35
EnteroMedics Announces Private Placement Of Shares For US$45 Million 36
EnteroMedics Completes Private Placement Of Shares For US$3.6 Million Upon Exercise Of Warrants 37
EnteroMedics Completes Private Placement Of Shares For US$5 Million 38
Acquisition 39
EnteroMedics Acquires ReShape Medical 39
EnteroMedics Acquires BarioSurg 41
ReShape Lifesciences Inc – Key Competitors 42
ReShape Lifesciences Inc – Key Employees 43
ReShape Lifesciences Inc – Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Recent Developments 45
Product News 45
Jun 05, 2018: ReShape Lifesciences Announces New Patent Grant Expanding its Bioelectronic and Neuromodulation Portfolio 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
ReShape Lifesciences Inc, Medical Equipment, Key Facts, 2017 2
ReShape Lifesciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ReShape Lifesciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ReShape Lifesciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ReShape Lifesciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ReShape Lifesciences Inc, Deals By Market, 2012 to YTD 2018 8
ReShape Lifesciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
EnteroMedics Raises USD61 Million in a Venture Financing 11
Reshape Medical Raises USD11 Million in Venture Financing 12
Reshape Medical Raises USD38 Million in Series D Financing 13
Reshape Medical Raises Additional USD3.5 Million in Venture Financing 15
Reshape Medical Raises Additional USD1.25 Million in Venture Financing 16
Reshape Medical Raises USD4 Million in Venture Financing 17
Reshape Medical Raises US$16 Million In Venture Financing 18
Reshape Medical Raises US$1.5 Million In Venture Financing 19
EnteroMedics Enters into Agreement with Galvani Bioelectronics 20
ReShape Lifesciences Plans to Raise USD15 Million in Public Offering of Shares 21
ReShape Lifesciences Prices Public Offering of Shares for USD0.5 Million 22
ReShape Lifesciences to Raise USD0.6 Million in Private Placement of Shares 23
ReShape Lifesciences Raises USD2.7 Million in Private Placement of Shares 24
ReShape Lifesciences Prices Registered Direct Offering of Shares for USD1.44 Million 25
ReShape Lifesciences to Raise USD6 Million in Private Placement of Shares and Warrants 26
EnteroMedics Raises USD20 Million in Public Offering of Units 28
EnteroMedics Raises USD19 Million in Public Offering of Units 30
EnteroMedics Raises USD16 Million in Public Offering of Units 32
EnteroMedics Announces Public Offering Of Common Stock For US$20 Million 34
EnteroMedics Completes Public Offering Of Common Stock And Warrants For US$13 Million 35
EnteroMedics Announces Private Placement Of Shares For US$45 Million 36
EnteroMedics Completes Private Placement Of Shares For US$3.6 Million Upon Exercise Of Warrants 37
EnteroMedics Completes Private Placement Of Shares For US$5 Million 38
EnteroMedics Acquires ReShape Medical 39
EnteroMedics Acquires BarioSurg 41
ReShape Lifesciences Inc, Key Competitors 42
ReShape Lifesciences Inc, Key Employees 43
ReShape Lifesciences Inc, Subsidiaries 44

List of Figures
ReShape Lifesciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ReShape Lifesciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ReShape Lifesciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ReShape Lifesciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ReShape Lifesciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ReShape Lifesciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ReShape Lifesciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ReShape Lifesciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[ReShape Lifesciences Inc (RSLS):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Ensign Group Inc (ENSG):企業の財務・戦略的SWOT分析
    The Ensign Group Inc (ENSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Meketa Investment Group:企業の戦略・SWOT・財務情報
    Meketa Investment Group - Strategy, SWOT and Corporate Finance Report Summary Meketa Investment Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Royal KPN N.V.:企業の戦略・SWOT・財務情報
    Royal KPN N.V. - Strategy, SWOT and Corporate Finance Report Summary Royal KPN N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Clementia Pharmaceuticals Inc (CMTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Clementia Pharmaceuticals Inc (Clementia) is a clinical stage biopharmaceutical company that focuses on the development of treatments for rare bone disorders and other diseases. Its lead product candidate Palovarotene is used for the treatment of fibrodysplasia ossificans progressiva (FOP), …
  • JEOL Ltd (6951):企業の財務・戦略的SWOT分析
    JEOL Ltd (6951) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Broadcom Inc (AVGO):企業の財務・戦略的SWOT分析
    Broadcom Inc (AVGO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Techtronic Industries Co Ltd (669)
    Techtronic Industries Co Ltd (669) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Cathay Life Insurance Co Ltd:企業の戦略・SWOT・財務分析
    Cathay Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Cathay Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Energinet.dk:企業の戦略的SWOT分析
    Energinet.dk - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • ProAxsis Ltd:製品パイプライン分析
    Summary ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases …
  • Kumiai Chemical Industry Co Ltd (4996):企業の財務・戦略的SWOT分析
    Summary Kumiai Chemical Industry Co Ltd (Kumiai Chemical) operates as a chemical company that develops, manufactures and markets agricultural chemicals, fine chemicals, and curing agents. The company's agricultural chemicals include bactericides, herbicides, fungicides, acaricides, microbial pestici …
  • Tadano Ltd:企業の戦略・SWOT・財務分析
    Tadano Ltd - Strategy, SWOT and Corporate Finance Report Summary Tadano Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • XPO Logistics, Inc.:企業のM&A・事業提携・投資動向
    XPO Logistics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's XPO Logistics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Medigen Biotechnology Corp (3176)-医療機器分野:企業M&A・提携分析
    Summary Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s pro …
  • Ulthera Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ulthera Inc (Ulthera), a subsidiary of Merz Pharma GmbH & Co KgaA is a medical device company that develops and commercializes technologies for aesthetic and medical applications by using its therapeutic ultrasound platform technologies. The company’s therapeutic ultrasound platform technolo …
  • NTT Data Corporation:企業のM&A・事業提携・投資動向
    NTT Data Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NTT Data Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Calfrac Well Services Ltd (CFW):企業の財務・戦略的SWOT分析
    Calfrac Well Services Ltd (CFW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Kallpa Generacion SA:企業の発電所・SWOT分析2018
    Kallpa Generacion SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Henry Lamotte Group:戦略・SWOT・企業財務分析
    Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report Summary Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Forrester Research Inc (FORR):企業の財務・戦略的SWOT分析
    Summary Forrester Research Inc (Forrester) is a market research company that offers research and advisory services. The company offers services such as custom consulting, proprietary research, consumer and business data, worldwide events and peer executive programs. Forrester provides research for p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆